Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancy.
Licitra EJ, Vyas V, Nelson K, Musanti R, Beers S, Thomas C, Poplin E, Smith S, Lin Y, Schaaf LJ, Aisner J, Gounder M, Rajendra R, Saleem A, Toppmeyer D, Rubin EH.
Licitra EJ, et al. Among authors: gounder m.
Clin Cancer Res. 2003 May;9(5):1673-9.
Clin Cancer Res. 2003.
PMID: 12738720
Clinical Trial.